Yttrium-90 Transarterial Radioembolization: An Effective Primary or Salvage Therapy to Bridge the Patients with Hepatocellular Carcinoma to Liver Transplantation

被引：1
|
作者：
Qu, Xudong [1 ]
Zhang, Feng [2 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Dept Intervent Radiol, Sch Med, Shanghai, Peoples R China
[2] Univ Washington, Sch Med, Dept Radiol, Seattle, WA 98109 USA
来源：
ACADEMIC RADIOLOGY | 2024年 / 31卷 / 05期
关键词：
CHEMOEMBOLIZATION;
D O I：
10.1016/j.acra.2024.02.027
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：1836 / 1838
页数：3
相关论文
共 50 条
  • [41] Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
    Yang, Yi
    Si, Tongguo
    CANCER BIOLOGY & MEDICINE, 2018, 15 (03) : 299 - 310
  • [42] A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
    Marnix Lam
    Etienne Garin
    Marco Maccauro
    S. Cheenu Kappadath
    Daniel Y. Sze
    Cuneyt Turkmen
    Murat Cantasdemir
    Paul Haste
    Ken Herrmann
    Hamad Saleh Alsuhaibani
    Matthew Dreher
    Kirk D. Fowers
    Riad Salem
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3340 - 3352
  • [43] Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma:a systematic review and meta-analysis
    Yi Yang
    Tongguo Si
    Cancer Biology & Medicine, 2018, 15 (03) : 299 - 310
  • [44] Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma
    Badar, Wali
    Van Ha, Thuong
    Zangan, Steven
    Navuluri, Rakesh
    Pillai, Anjana
    Baker, Talia
    Ahmed, Osman
    GASTROINTESTINAL TUMORS, 2020, 7 (04) : 144 - 150
  • [45] Efficacy of Radioembolization Treatments With Yttrium-90 Microspheres for Hepatocellular Carcinoma and Liver Metastases
    Ziegler, M. A.
    Kumar, R.
    Wild, A. T.
    Pawlik, T. M.
    Kamel, I. R.
    Herman, J. M.
    Geschwind, J. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S339 - S340
  • [46] Contralateral Hypertrophy Post Yttrium-90 Transarterial Radioembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus
    Hadjivassiliou, Anastasia
    Hou, Xinchi
    Cardarelli-Leite, Leandro
    Klyuzhin, Ivan S.
    Benard, Francois
    Klass, Darren
    Ho, Stephen G. F.
    Rahmim, Arman
    Liu, David
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [47] Resin-Based Yttrium-90 Radioembolization as a Bridging or Downstaging Treatment to Liver Transplantation for Hepatocellular Carcinoma
    Bonne, Lawrence
    Deroose, Christophe M.
    Verslype, Chris
    Monbaliu, Diethard
    Dekervel, Jeroen
    Van Laeken, Charlotte
    Vandecaveye, Vincent
    Laenen, Annouschka
    Pirenne, Jacques
    Maleux, Geert
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2025, 36 (02) : 282 - 292
  • [48] LIVER TRANSPLANTATION AFTER RADIOEMBOLIZATION WITH YTTRIUM-90 MICROSPHERES
    Radunz, Sonia
    Sotiropoulos, Georgios C.
    Schlaak, Joerg
    Bockisch, Andreas
    Lauenstein, Thomas
    Baba, Hideo A.
    Paul, Andreas
    Treckmann, Jurgen W.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 314 - 314
  • [49] YTTRIUM-90 MICROSPHERES FOR THE TREATMRNT OF HEPATOCELLULAR CARCINOMA IN PATIENTS NOT ELIGIBLE FOR LIVER TRANSPLANTATION
    Koom-Dadzi, Kwami
    Patel, Kandarp
    Little, Ester
    Hirsh, Kevin
    David, Wood
    Wong, Mark
    Moore, Ann
    Ramos, Alberto
    Kolli, Geetha
    Gerkin, Richard
    Manch, Richard
    LIVER TRANSPLANTATION, 2008, 14 (07) : S122 - S122
  • [50] Transarterial radioembolization with yttrium-90 of unresectable primary hepatic malignancy in children
    Aguado, Allison
    Ristagno, Ross
    Towbin, Alexander J.
    Gupta, Anita
    Haberle, Sinisa
    Qi, Zhihua
    Patel, Manish N.
    Kukreja, Kamlesh U.
    Tiao, Gregory M.
    Geller, James I.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (07)
12345